Alana T Brennan, PhD

Publications

• Published on 12/10/2025

  Sass N, Havrylenko H, Gerber F, Amstutz A, Rosen S, Brennan A, Maskew M, Koenig S, Dorvil N, Geng EH, Glass T, Ford NP, Labhardt ND, Schandelmaier S. Effect of same-day HIV treatment initiation (SDI) on 1-year outcomes in low- and middle-income countries: systematic review and meta-analysis of randomised trials. BMJ Glob Health. 2025 Dec 10; 10(12). PMID: 41371927.

  Read At: PubMed

• Published on 12/1/2025

  Dzomba A, Shumba K, Nattey C, Lauren E, Brennan AT, McLoed W, Fox MP, Bor J, Onoya D. HIV Patient Treatment Adherence Trajectories in First 24 months After ART Initiation Among Adults: An Electronic Health Records Cohort From South Africa. J Acquir Immune Defic Syndr. 2025 Dec 01; 100(4):305-314. PMID: 40778758.

  Read At: PubMed

• Published on 9/22/2025

  Zheng A, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Murray EJ, Pisa PT, Goeieman B, Fox MP, Maskew M. Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation. Infect Dis (Lond). 2025 Sep 22; 1-11. PMID: 40982349.

  Read At: PubMed

• Published on 9/1/2025

  Zheng A, Kileel EM, Brennan AT, Flynn DB, Rosen S, Fox MP. Systematic review and meta-analysis of retention and disengagement after initiation on antiretroviral therapy in low- and middle-income countries after the introduction of Universal Test and Treat policies. J Int AIDS Soc. 2025 Sep; 28(9):e70026. PMID: 40908808.

  Read At: PubMed

• Published on 6/1/2025

  Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Brennan AT, Maskew M. Initiation of Dolutegravir Versus Efavirenz on Viral Suppression and Retention at 6 months: A Regression Discontinuity Design. J Acquir Immune Defic Syndr. 2025 Jun 01; 99(2):151-157. PMID: 39913899.

  Read At: PubMed

• Published on 1/6/2025

  Chabala FW, Siew ED, Wester CW, Brennan AT, Phiri MM, Vinikoor MJ, Masenga SK, Aliyu MH. Urine kidney injury molecule-1 predicts subclinical kidney disease among persons living with HIV initiating tenofovir disoproxil fumarate-based ART in Zambia. Front Nephrol. 2024; 4:1468409. PMID: 39834612.

  Read At: PubMed

• Published on 1/1/2025

  Brennan AT, Scott N, Shubber Z, Cook A, Fraser-Hurt N, Peters MA, Scott VK, Elsamman A, Rosen S, Kaiser J, Juntunen A, Kuhfeldt K, Paudel R, Housman L, Fraser L, O’Neil E, Gadea VE. . World Bank. Delivering Primary Care for Non-Communicable Diseases: A Compendium of Service Delivery Models in Low- and Middle-Income Countries. 2025.

  Read At: Custom

• Published on 12/18/2024

  Zheng A, Kileel EM, Brennan AT, Flynn DB, Rosen S, Fox MP. Systematic Review and Meta-Analysis of Retention and Disengagement After Initiation on Antiretroviral Therapy in Low- and Middle-Income Countries After the Introduction of Universal Test and Treat Policies. medRxiv. 2024 Dec 18. PMID: 39763529.

  Read At: PubMed

• Published on 9/3/2024

  Brennan AT, Kileel EM, Fox MP, George JA, Khoza S, Rosen S, Raal F, Hibberd P, Chetty K, Mlisana K, Bor J, Crowther NJ. Assessing compliance with national guidelines in diabetes care: A study leveraging data from south Africa's National Health Laboratory Service (NHLS). PLOS Glob Public Health. 2024; 4(9):e0003014. PMID: 39226276.

  Read At: PubMed

• Published on 7/30/2024

  Brennan AT, Kileel EM, Khoza S, Crowther NJ, Bor J, Fox MP, Rosen S, Hibberd P, Raal F, Chetty K, Mlisana K, George JA. Prevalence and progression of chronic kidney disease among adults undergoing creatinine testing in South African public healthcare facilities: a study leveraging data from South Africa's National Health Laboratory Service (NHLS). BMJ Public Health. 2024 Jul; 2(1). PMID: 39698394.

  Read At: PubMed

View 82 more publications:View Full Profile at BUMC